E-Book | March 7, 2021

Manufacturing Sterile Parenteral Pharmaceuticals: How To Protect Oxygen Sensitive Formulations

By Derek Duncan

Lighthouse

How well do you protect your oxygen sensitive formulations during filling? Many biopharmaceutical drug formulations have some degree of oxygen sensitivity. Monitoring the headspace gas composition of oxygen-sensitive product during filling serves as an in-process control of the nitrogen purging and can help ensure that the product being produced will retain stability and efficacy. This E-Book describes how to protect oxygen sensitive formulations, covering methods for in-process monitoring of oxygen, nitrogen purge optimization and validation, including nitrogen purge qualification and process development data of a manufacturing filling line.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online